Docetaxel Injection IP
Docetaxel Injection IP

Docetaxel Injection IP

Price 300 INR/ Vial

MOQ : 1 Vial

Docetaxel Injection IP Specification

  • Salt Composition
  • Docetaxel
  • Indication
  • Breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, head and neck cancer
  • Dosage Form
  • Injection
  • Feature
  • Sterile, single-use, cytotoxic injectable
  • Ingredients
  • Docetaxel, polysorbate 80, ethanol anhydrous, water for injection
  • Application
  • Ph Level
  • Neutral (pH 3.05.0)
  • Physical Color/Texture
  • Clear, colorless to pale yellow solution
  • Fermentation Smell
  • Characteristic, alcoholic smell
  • Storage Instructions
  • Store below 25C, protect from light
  • Shelf Life
  • 24 months
  • Pack Size
  • Single-dose vial
  • Precautions
  • Use under physician supervision, cytotoxic precautions required
  • Route of Administration
  • Intravenous
  • Available Strengths
  • 20 mg/0.5 ml, 80 mg/2 ml, 120 mg/3 ml
  • Solubility
  • Soluble in polysorbate 80 and ethanol
  • Packaging Type
  • Glass vial with flip-off seal
  • Prescription Status
  • Prescription only (Rx)
  • Compatibility
  • Use only with recommended diluents and IV sets
  • Regulatory Classification
  • Schedule H (India)
 
 

About Docetaxel Injection IP



Sale Ending Soon! Grab Yours Now-Docetaxel Injection IP offers first-class anti-cancer chemotherapy with flawless performance for unparalleled patient care. Available in 20 mg/0.5 ml, 80 mg/2 ml, and 120 mg/3 ml strengths, this sterile, single-use, cytotoxic prescription injectable is delivered in a secure glass vial with a flip-off seal. Specifically designed for intravenous administration, it is soluble in polysorbate 80 and ethanol, and is indicated for breast, lung, prostate, gastric, and head and neck cancers. Ensure compliance with cytotoxic precautions and physician supervision. Perfect for distributors, exporters, suppliers, and traders across India.

Directions, Usage, and Indications of Docetaxel Injection IP

Docetaxel Injection IP is intended for intravenous administration only and must be used strictly as directed by a qualified healthcare provider. This prescription-only medicine serves as a potent chemotherapeutic agent for treating breast, non-small cell lung, prostate, gastric, and head and neck cancers. It is designed for general hospital and clinical use under cytotoxic precautions, ensuring patient safety and efficacy. Adherence to specified diluents and administration sets is essential for optimal therapeutic outcomes.


Export Market, Delivery, and Packaging Details for Docetaxel Injection IP

Docetaxel Injection IP is available for domestic distribution across India and holds a robust presence in the export market. Packaging includes a sterile, glass vial with a flip-off seal to guarantee product integrity during delivery and storage. Each order is promptly dispatched following strict sample policy and regulatory compliance, ensuring timely and safe supply to distributors and hospitals. Shelf life is guaranteed for 24 months when stored below 25C and protected from light.


FAQ's of Docetaxel Injection IP:


Q: How should Docetaxel Injection IP be administered safely?

A: Docetaxel Injection IP is to be administered intravenously by a trained healthcare professional in a clinical or hospital setting. Strict adherence to cytotoxic safety precautions and the use of recommended diluents and IV sets is required.

Q: What are the main indications for using Docetaxel Injection IP?

A: This medication is primarily indicated for the treatment of cancers such as breast, non-small cell lung, prostate, gastric, and head and neck cancers.

Q: When should Docetaxel Injection IP be used?

A: Docetaxel Injection IP should be used strictly under a physician's supervision and only after being prescribed as part of a comprehensive anti-cancer chemotherapy protocol.

Q: Where can I purchase or distribute Docetaxel Injection IP?

A: Docetaxel Injection IP is available through licensed distributors, exporters, suppliers, and traders across India, complying with Schedule H regulations.

Q: What precautions must be taken during the handling and storage of Docetaxel Injection IP?

A: Handle with cytotoxic precautions, store below 25C, protect from light, and always use sterile techniques to maintain product efficacy and safety.

Q: What are the benefits of choosing Docetaxel Injection IP for chemotherapy?

A: It offers first-class, reliable, and effective treatment options for various cancers, packaged in single-dose sterile vials that ensure both safety and convenience.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti Cancer Injection Category

500 Mg 50 Ml Rituximab

500 Mg 50 Ml Rituximab

Price 5999 INR / Vial

Minimum Order Quantity : 1 Vial

Shelf Life : 24 Months

Dosage Form : Injection

Storage Instructions : Store at 28C, do not freeze, protect from light

Indication : NonHodgkins Lymphoma, Chronic Lymphocytic Leukemia, Rheumatoid Arthritis

260 Mg Paclitaxel Injection IP

260 Mg Paclitaxel Injection IP

Price 800 INR / Vial

Minimum Order Quantity : 1 Vial

Shelf Life : 24 months

Dosage Form : Injection

Storage Instructions : Store below 25C, protect from light

Indication : Anticancer, ovarian cancer, breast cancer, nonsmall cell lung cancer

300 Mg - 12 Ml Bevacizumab Injection

300 Mg - 12 Ml Bevacizumab Injection

Price 10000 INR / Vial

Minimum Order Quantity : 1 Vial

Shelf Life : 24 months from manufacturing date

Dosage Form : Injection

Storage Instructions : Store refrigerated at 2C to 8C. Do not freeze.

Indication : Cancer Treatment (Colorectal Cancer, Lung Cancer, Renal Cell Carcinoma, Glioblastoma)

Zoledronic Acid Injection IP

Zoledronic Acid Injection IP

Price 500 INR / Vial

Minimum Order Quantity : 1 Vial

Shelf Life : 24 months

Dosage Form : Injection

Storage Instructions : Store below 25C, protect from light, do not freeze

Indication : Treatment of osteoporosis, Pagets disease, hypercalcemia of malignancy, bone metastases



Back to top